Reduced β-catenin expression is associated with good prognosis in astrocytoma

Pathology and Oncology Research

Volumn 16, Issue 2, 2010, Pages 253-257

  Zhang, Li Ying ^a   Jiang, Li Na ^a   Li, Fan Fan ^a   Li, Hang ^a   Liu, Fang ^a   Gu, Yu ^a   Song, Yue ^a   Zhang, Feng ^a   Ye, Jing ^a   Li, Qing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

catenin; Astrocytoma; Immunohistochemistry; Prognosis

Indexed keywords

BETA CATENIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTROCYTOMA; BRAIN SURGERY; CANCER GRADING; CANCER SURVIVAL; CELL MEMBRANE; CELL NUCLEUS; CHILD; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SEX DIFFERENCE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BETA CATENIN; BRAIN NEOPLASMS; CHILD; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77955710186     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9219-0     Document Type: Article

References (21)

1. Louis DN (1997) A molecular genetic model of astrocytoma histopathology. Brain Pathol 7:755-764
2. Baeza N, Masuoka J, Kleihues P et al. (2003) AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22:632-636
3. Collins VP (1995) Genetic alterations in gliomas. J Neurooncol 24:37-38
4. Nelson WJ, Nusse R (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303:1483-1487
5. Ilyas M (2005) Wnt signalling and the mechanistic basis of tumour development. J Pathol 205:130-144
6. Van Aken E, De Wever O, Correia da Rocha AS et al. (2001) Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 439:725-751
7. Lustig B, Behrens J (2003) The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129:199-221
8. Doucas H, Garcea G, Neal CP et al. (2005) Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41:365-379
9. Ueta T, Ikeguchi M, Hirooka Y et al. (2002) Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Oncol Rep 9:1197-1203
10. Gerstein AV, Almeida TA, Zhao G et al. (2002) APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34:9-16
11. Ashihara K, Saito T, Mizumoto H et al. (2002) Mutation of betacatenin gene in endometrial cancer but not in associated hyperplasia. Med Electron Microsc 35:9-15
12. Utsuki S, Sato Y, Oka H et al. (2002) Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 57:187-192
13. Henderson BR, Fagotto F (2002) The ins and outs of APC and beta-catenin nuclear transport. EMBO Rep 3:834-839
14. Novak A, Dedhar S (1999) Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56:523-537
15. Akiyama T (2000) Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 11:273-282
16. Polakis P (2000) Wnt signaling and cancer. Genes Dev 14:1837-1851
17. Morin PJ (1999) beta-catenin signaling and cancer. Bioessays 21:1021-1030
18. Wijnhoven BP, Dinjens WN, Pignatelli M (2000) E-cadherincatenin cell-cell adhesion complex and human cancer. Br J Surg 87:992-1005
19. Woo DK, Kim HS, Lee HS et al. (2001) Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int J Cancer 95:108-113
20. Grabsch H, Takeno S, Noguchi T et al. (2001) Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome. Histopathology 39:141-149
21. Zeng JZ, Hui Z, Rao HL, Zhang M, Hou J, Hui W, Qiu L (2004) Expression of cytoskeleton proteins α- and β-catenin in gliomas. China Cancer 11:0738-0740